A Randomized Controlled Clinical Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

November 1, 2026

Conditions
Androgenic Alopecia
Interventions
DRUG

Human umbilical cord mesenchymal stem cell exosomes

Human umbilical cord mesenchymal stem cell exosomes are nanoscale vesicles released by mesenchymal stem cells from the umbilical cord. These exosomes act as natural carriers, transferring proteins, microRNAs (miRNAs), and other molecules to recipient cells. This communication helps the exosomes exert therapeutic effects, promoting tissue repair, reducing inflammation, and mediating cell-to-cell interactions in various disease models.

DRUG

Minoxidil 5% Topical Solution

Topical minoxidil is a medicine used to help regrow the hair on your scalp. It works by increasing the blood flow to your hair and helps stimulate your hair follicles to grow.

Trial Locations (1)

518020

RECRUITING

Shenzhen People's Hospital, Shenzhen

All Listed Sponsors
lead

Shenzhen People's Hospital

OTHER

NCT07203599 - A Randomized Controlled Clinical Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes | Biotech Hunter | Biotech Hunter